PREMAL LULLA to Clinical Trials as Topic
This is a "connection" page, showing publications PREMAL LULLA has written about Clinical Trials as Topic.
Connection Strength
0.262
-
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice. Hum Vaccin Immunother. 2024 12 31; 20(1):2378543.
Score: 0.159
-
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2018 May; 16(5):375-386.
Score: 0.103